TRANSBOUNDARY MARKET ESTABLISHMENT AS A STRATEGY OF THE PHARMACEUTICS DEVELOPMENT IN RUSSIA UNDER SANCTIONS

Abstract

Vladimir A. Zernov, Anastasia E. Lobanova, Natalia S. Klunko.

The subject of the article is the strategy for the pharmaceutics development under sanctions in Russia, taking into consideration the possibility to create the transboundary pharmaceutical market with the participation of Russia and China. The approach is believed to be relevant because currently Russia depends on imported pharmaceutical products and, although the sanctions have not affected pharmaceutical products, however, the high importance of pharmaceutical products imported from Western countries makes Russia to think about possible consequences of further expansion of the sanctions for national security. Currently the Russian market is reacting to the possible situation if foreign companies leave the market in case of toughening sanctions, and these apprehensions make the authorities and the national pharmaceutical business search for new ways of economic integration, realizing that the resulting synergistic effect may become the most important "growth point" for the Russian pharmaceutical industry. Development of transboundary cooperation between Russia and foreign participants of the pharmaceutical market seems to be one of the possible strategic decisions contributing to a synergistic growth of the pharmaceutical industry in Russia. The issue urgency determined the research directions. The possibility of transboundary cooperation between China and Russia based on public-private partnerships, and of the transboundary pharmaceutical market creation has been substantiated herein; recommendations on the transboundary pharmaceutical cluster establishment in China and Russia have been developed; the significance of the factors determining the possibility to build the clusters and to restrict this process have been identified; recommendations regarding the participants of the build cluster have been formulated.